Nanosys and SEMATECH Collaborate to Develop Advanced Material Technology

SEMATECH today announced that Nanosys, Inc., an advanced materials architect, has joined its Front End Processes (FEP) program, and will work with SEMATECH to develop new materials and processing techniques for extending flash memory technologies.

As a member of this program, Nanosys will closely collaborate with experts from SEMATECH’s FEP research team, and leverage SEMATECH activities in advanced process integration and materials and device characterization to extend non-volatile memory for the 2X nm node and beyond. Specifically, SEMATECH and Nanosys plan to build a material and process infrastructure to enable and extend both planar and future three-dimensional non-volatile memory technologies.

“SEMATECH is pleased to welcome Nanosys as a partner,” said Raj Jammy, SEMATECH vice president of emerging technologies. “Nanosys’ unique expertise in process-ready, advanced material technology will complement our own device and process expertise. We will work together to develop practical and promising approaches to address the continued scaling needs of the fast-growing non-volatile memory market.”

“SEMATECH provides Nanosys with an excellent development platform for our next generation Quantum Dot Memory (QDMTM) technology,” said Jason Hartlove, CEO of Nanosys. “This collaboration will further the commercialization of our advanced materials and yield solutions that are critical to the continued progress of the memory roadmap.”

The goal of SEMATECH’s FEP program is to provide novel leading-edge materials, processes, structural modules and electrical and physical characterization solutions to support the continued scaling of logic and memory applications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.